Botox Therapeutics
The Top Pharma List rankings are compiled from GlobalData’s pharmaceutical revenue figures, which are based on prescription medicine sales, including generics drugs. Listed below are the charts and positions for Botox Therapeutics in this year’s pharmaceutical sales data alongside recent articles on PMLiVE featuring Botox Therapeutics.
50
Global Revenue Ranking
Recent articles on PMLiVE featuring Botox Therapeutics
Speciality drugmaker posted a 6.6% sales increase in the last quarter
A rapid round up of pharma, biotech and healthcare news
Decision comes despite less than stellar clincial data
Acquired company focuses on plastic surgery and hernia repair procedures
Allergan’s $2.1bn acquisition of Kythera tops this month’s deals
Deal Watch: Major pharma collaborations, acquisitions and agreements in the past month
Deal Watch: Major pharma collaborations, acquisitions and agreements in the past month
Data provided by GlobalData
GlobalData provides trusted intelligence on the world’s largest industries including Pharmaceutical and Medical Devices. With over 2,000 in-house experts, our data-driven, technology-powered approach delivers gold-standard insights to help businesses navigate complex markets and predict future trends.
Our integrated platform empowers 4,000 of the world’s largest companies—including over 70% of FTSE 100 and 60% of Fortune 100 firms—to make timely, informed decisions through unique data, expert analysis, and innovative consulting solutions.
To find out more about how our research and insights can help you, please visit https://www.globaldata.com/who-we-are/why-globaldata/
For more details on the data and methodology used to create the Top Pharma Lists, please visit PMLiVE’s Top Pharma List – Methodology